The introduction of an oxime group into an appropriate chemical backbone has produced very effective AChE reactivators, various kinase inhibitors, and compounds with antibacterial, anticancer, anti-inflammatory, anti-arthritis, and anti-stroke activities [48,49]. This evidence concerns the gene ACHE and arthritic joint disease.